The Clinical Study of Acute Pancreatitis Treated by TongFuSan

NCT02204189 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2014-07-30

No results posted yet for this study

Summary

The purpose of this study is to determine whether TongFuSan is effective in the treatment of acute pancreatitis with gastrointestinal dysfunction.

Conditions

Interventions

DRUG

TongFuSan

TongFuSan 1g

Sponsors & Collaborators

  • Beijing Friendship Hospital

    lead OTHER

Principal Investigators

  • Bin Miao, PHD · Beijing Friendship Hospital

  • Hong Wang, Graduate · Beijing Friendship Hospital

  • Shuwen Zhang, bachelor · Beijing Friendship Hospital

  • Chao Wang, PHD · Beijing Friendship Hospital

  • Yanli Su, PHD · Beijing Friendship Hospital

  • Shirong Li, graduate · Beijing Friendship Hospital

  • Fengwu Li, graduate · Beijing Friendship Hospital

  • Dinghua Xu, graduate · Beijing Friendship Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2014-10-31
Completion
2017-02-28

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02204189 on ClinicalTrials.gov